Yukihiro Hamada

1.9k total citations
102 papers, 1.4k citations indexed

About

Yukihiro Hamada is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Yukihiro Hamada has authored 102 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 36 papers in Pharmacology and 33 papers in Epidemiology. Recurrent topics in Yukihiro Hamada's work include Antibiotics Pharmacokinetics and Efficacy (34 papers), Antimicrobial Resistance in Staphylococcus (24 papers) and Antifungal resistance and susceptibility (19 papers). Yukihiro Hamada is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (34 papers), Antimicrobial Resistance in Staphylococcus (24 papers) and Antifungal resistance and susceptibility (19 papers). Yukihiro Hamada collaborates with scholars based in Japan, United States and Saudi Arabia. Yukihiro Hamada's co-authors include Toshimi Kimura, Yoshio Takesue, Yoshiko Takahashi, Kazuaki Matsumoto, David P. Nicolau, Hiroshige Mikamo, Satoshi Fujii, Kazuo Yago, Makoto Samukawa and Norio Ohmagari and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Anesthesiology.

In The Last Decade

Yukihiro Hamada

94 papers receiving 1.4k citations

Peers

Yukihiro Hamada

PHARM

EPIDE

NEURO

Nicholas M. Moore United States

Robert Sauermann Austria

Rosario Amaya‐Villar Spain

Romain Guilhaumou France

Kazuro Ikawa Japan

Jiao Xie China

Edith Lackner Austria

Rosa Zampino Italy

Julie Passarell United States

David P. Benziger United States

Nicholas M. Moore United States

Yukihiro Hamada

286 ×0.4

158 ×0.3

PHARM

264 ×0.6

EPIDE

174 ×0.6

56 ×0.4

NEURO

Citations per year, relative to Yukihiro Hamada Yukihiro Hamada (= 1×) peers Nicholas M. Moore

Countries citing papers authored by Yukihiro Hamada

Since Specialization

Citations

This map shows the geographic impact of Yukihiro Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukihiro Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukihiro Hamada more than expected).

Fields of papers citing papers by Yukihiro Hamada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukihiro Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukihiro Hamada. The network helps show where Yukihiro Hamada may publish in the future.

Co-authorship network of co-authors of Yukihiro Hamada

This figure shows the co-authorship network connecting the top 25 collaborators of Yukihiro Hamada. A scholar is included among the top collaborators of Yukihiro Hamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukihiro Hamada. Yukihiro Hamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kawada, Kei, Chiemi Sato, Tomoaki Ishida, et al.. (2025). Vitamin D Supplementation and Allergic Rhinitis: A Systematic Review and Meta-Analysis. Medicina. 61(2). 355–355.

Ishida, Tomoaki, Kei Kawada, Kohei Jobu, et al.. (2025). Impact of comorbid constipation on the survival of patients with heart failure: a multicenter, prospective cohort study conducted in Japan. Frontiers in Cardiovascular Medicine. 11. 1470216–1470216. 1 indexed citations

Ishida, Tomoaki, Kohei Jobu, Takahiro Kato, et al.. (2025). Evaluation of Adverse Events Associated with the Sulfamethoxazole/Trimethoprim Combination Drug. Journal of Clinical Medicine. 14(14). 4819–4819.

Kasai, Hidefumi, et al.. (2024). Drug–drug interactions between letermovir and tacrolimus in Japanese renal transplant recipients simulated using a physiologically based pharmacokinetic model. Frontiers in Microbiology. 15. 1480874–1480874.

Yagi, Yusuke, Yuka Yamagishi, & Yukihiro Hamada. (2024). Optimized Antifungal Therapy for Chronic Pulmonary Aspergillosis. Medical Mycology Journal. 65(3). 59–65. 1 indexed citations

Kato, Hideo, Takumi Umemura, Mao Hagihara, et al.. (2024). Development of a therapeutic drug‐monitoring algorithm for outpatients receiving voriconazole: A multicentre retrospective study. British Journal of Clinical Pharmacology. 90(5). 1222–1230. 4 indexed citations

Hanai, Yuki, Takashi Ueda, Yukihiro Hamada, et al.. (2023). Optimal timing for therapeutic drug monitoring of voriconazole to prevent adverse effects in Japanese patients. Mycoses. 66(12). 1035–1044. 6 indexed citations

Kimura, Toshimi, et al.. (2023). Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection. Journal of Infection and Chemotherapy. 29(12). 1152–1159. 2 indexed citations

Takesue, Yoshio, Yuki Hanai, Kazutaka Oda, et al.. (2022). Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Clinical Therapeutics. 44(12). 1604–1623. 37 indexed citations

10.

Matsumoto, Kazuaki, Kazutaka Oda, Kensuke Shoji, et al.. (2022). Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Pharmaceutics. 14(3). 489–489. 78 indexed citations

11.

Hamada, Yukihiro, et al.. (2022). Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan. International Journal of Environmental Research and Public Health. 19(5). 2516–2516. 3 indexed citations

12.

Hanai, Yuki, Yukihiro Hamada, Toshimi Kimura, et al.. (2021). Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis. Journal of Fungi. 7(4). 306–306. 24 indexed citations

13.

Mizukami, Yuki, Yuki Enoki, Kazuaki Taguchi, et al.. (2021). The optimal trough-guided monitoring of vancomycin in children: Systematic review and meta-analyses. Journal of Infection and Chemotherapy. 27(5). 781–785. 4 indexed citations

14.

Hanai, Yuki, Yoshiko Takahashi, Takashi Niwa, et al.. (2021). Optimal trough concentration of teicoplanin for the treatment of methicillin‐resistant Staphylococcus aureus infection: A systematic review and meta‐analysis. Journal of Clinical Pharmacy and Therapeutics. 46(3). 622–632. 17 indexed citations

15.

Hamada, Yukihiro, et al.. (2021). Retrospective evaluation of appropriate dosing of cefmetazole for invasive urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli. Journal of Infection and Chemotherapy. 27(11). 1602–1606. 11 indexed citations

16.

Hanai, Yuki, Yukihiro Hamada, Toshimi Kimura, et al.. (2020). Optimal trough concentration of voriconazole with therapeutic drug monitoring in children: A systematic review and meta-analysis. Journal of Infection and Chemotherapy. 27(2). 151–160. 20 indexed citations

17.

Nakane, Shunya, Osamu Higuchi, Yukihiro Hamada, et al.. (2016). Ganglionic acetylcholine receptor autoantibodies in patients with Guillain-Barré syndrome. Journal of Neuroimmunology. 295-296. 54–59. 8 indexed citations

18.

Hamada, Yukihiro, Hiroyuki Suematsu, Jun Hirai, Yuka Yamagishi, & Hiroshige Mikamo. (2014). [Evaluation of six cases of arbekacin inhalation for pneumonia].. PubMed. 67(4). 233–9. 3 indexed citations

19.

Hamada, Yukihiro, Hisashi Naıto, Shunsuke Miyamoto, et al.. (2007). Methicillin-Resistant Staphylococcus aureus (MRSA) Medication with Head and Neck Tumor. Practica Oto-Rhino-Laryngologica. 100(4). 303–307.

20.

Hamada, Yukihiro, et al.. (1998). ES-242-1(ラットにおける侵害知覚の上の新規NMDA受容体アンタゴニスト)の効果. Anesthesiology. 89. 937. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact